HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR‐181a‐5p or KPNA2/cGAS‐STING/IFN‐I signaling
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Lina Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Cancer Biology, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Canc…. Hauptthemen laut MEDLINE: Hepatitis B, MicroRNAs. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Viral immune evasion is crucial to the pathogenesis of hepatitis B virus (HBV) infection. However, the role of HBV in the modulation of innate immune evasion is poorly understood. A liver‐specific histone acetyltransferase 1 ( Hat1 ) knockout (KO) mouse model and HAT1 KO cell line were established. Immunohistochemistry staining, Western blot analysis, Southern blot analysis, Northern blot analysis, immunofluorescence assays, enzyme‐linked immunosorbent assay, reverse transcription‐quantitative polymerase chain reaction, and chromatin immunoprecipitation assays were performed in the livers of mouse models, primary human hepatocytes, HepG2‐NTCP, and Huh7 and HepG2 cell lines. HBV‐elevated HAT1 increased the expression of miR‐181a‐5p targeting cyclic GMP‐AMP synthase (cGAS) messenger RNA 3′ untranslated regions through modulating acetylation of H4K5 and H4K12 in vitro and in vivo, leading to the inability of cGAS‐stimulator of interferon genes (STING) pathway and type I interferon (IFN‐I) signaling. Additionally, HBV‐elevated HAT1 promoted the expression of KPNA2 through modulating acetylation of H4K5 and H4K12 in the system, resulting in nuclear translocation of cGAS, HBx was responsible for the events by HAT1, suggesting that HBV‐elevated HAT1 controls the cGAS‐STING pathway and IFN‐I signaling to modulate viral innate immune evasion. HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR‐181a‐5p or KPNA2/cGAS‐STING/IFN‐I signaling. Our finding provides new insights into the mechanism by which HBV drives viral innate immune evasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Cancer Biology, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Cancer Institute, Liver Cancer Center, Tianjin Medical University Cancer I…
- Department of Cancer Research, Institute of Molecular Biology, College of Life Sciences, Nankai University, Tianjin, China.
- Department of Hepatobiliary Oncology, Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, L., Yuan, H., Wang, Y., Geng, Y., Yun, H., Zheng, W., Yuan, Y., Lv, P., Hou, C., Zhang, H., Sun, J., Sun, L., Suo, Y., Wang, S., Zhang, N., Lu, W., Yang, G., & Zhang, X. (2023). HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR‐181a‐5p or KPNA2/cGAS‐STING/IFN‐I signaling. Journal of Medical Virology. https://doi.org/10.1002/jmv.28966
Vancouver
Zhao L, Yuan H, Wang Y, Geng Y, Yun H, Zheng W, et al. HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR‐181a‐5p or KPNA2/cGAS‐STING/IFN‐I signaling. Journal of Medical Virology. 2023. doi:10.1002/jmv.28966
BibTeX
@article{Zhao2023,
author = {Zhao, Lina and Yuan, Hongfeng and Wang, Yufei and Geng, Yu and Yun, Haolin and Zheng, Wei and Yuan, Ying and Lv, Pan and Hou, Chunyu and Zhang, Huihui and Sun, Jiao and Sun, Linlin and Suo, Yuhong and Wang, Shuai and Zhang, Ningning and Lu, Wei and Yang, Guang and Zhang, Xiaodong},
title = {HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR‐181a‐5p or KPNA2/cGAS‐STING/IFN‐I signaling},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28966}
}
EUVIMED